ACCESS Calculator — Inputs

Total Panel Size
eCKM Eligible
CKM Eligible
MSK Eligible
BH Eligible
eCKM: 49.1% of panel
CKM: 59.0% of panel
MSK: 38.0% of panel
BH: 45.4% of panel
Y2 Growth Rate
%
Y3 Growth Rate
%
New eligible patients:
eCKM: Y2 +35,881 / Y3 +50,234
CKM: Y2 +43,145 / Y3 +60,403
MSK: Y2 +27,766 / Y3 +38,873
BH: Y2 +33,218 / Y3 +46,505
Mode
Penetration Rate
%
Ramp Periodⓘ
12 mo
Control Groupⓘ
Year 1:
Year 2:
Year 3:
Peak enrolled (Cohort 1):
eCKM: 20,183
CKM: 24,269
MSK: 15,619
BH: 18,685
Annual Churn Rate
%
Monthly: 1.7%
Multi-Track Overlapⓘ
%
⚠ Overlap data pending from data science team
Cost-Sharing Policy
Rural Patient %
%
Pearl Revenue Share
%
Outcome Attainment Rate (OAR)
eCKM OAR
%
CKM OAR
%
MSK OAR
%
BH OAR
%
OAT (M19–36)ⓘ
%
M1–18 OAT: 50% (fixed by CMS)
Substitute Spend Rate (SSR)
eCKM SSR
%
CKM SSR
%
MSK SSR
%
BH SSR
%

Outputs

Show tracks:

Summary Metrics by Year

Gross OAP RevNet OAP RevPearl Net RevPeak EnrolledBlended Adj.
Year 1$9.71M$8.35M$1.67M71,92314.1%
Year 2$16.33M$12.64M$2.53M90,75222.6%
Year 3$18.46M$12.65M$2.53M118,92831.5%
3-Year Total$44.50M$33.64M$6.73M118,92824.4%

Pearl Net Revenue by Track & Year

Each segment shows a track's contribution to Pearl's net revenue per year

Performance Adjustment Transparency

TrackClinical OAREffective OAROAT M1–18OAT M19–36COA (early)SSRSSTSSAApplied (early)Type
eCKM55.0%44.0%50.0%62.5%12.0%92.0%90.0%0.0%12.0%COA
CKM55.0%44.0%50.0%62.5%12.0%92.0%90.0%0.0%12.0%COA
MSK50.0%40.0%50.0%62.5%20.0%90.0%90.0%0.0%20.0%COA
BH50.0%40.0%50.0%62.5%20.0%92.0%90.0%0.0%20.0%COA